IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 12.3% in the 4th quarter, according to the company in its most recent ...

DAVENPORT & Co LLC lowered its position in IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 88.4% during the 4th quarter, ...

Deals, pipeline updates and geopolitical issues drove the conversation at the 2025 JP Morgan Healthcare conference.

According to research by nova one advisor, the global cell and gene therapy market size was valued at $18.13 billion in 2023 ...

Q4 2024 Earnings Call Transcript February 6, 2025 IQVIA Holdings Inc. beats earnings expectations. Reported EPS is $3.12, ...

IQVIA Holdings Inc (IQV) reports robust financial performance with record free cash flow and strategic partnership renewals, ...

Q4 2024. Management View. CEO Ari Bousbib highlighted that IQVIA achieved solid revenue growth of 5.5% at constant currency ...

IQVIA reaffirms its 2025 outlook, projecting up to $16.13 billion in revenue and EPS of $11.70-$12.10. Strong TAS growth and ...

Although the revenue and EPS for IQVIA (IQV) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street ...

Contract research firm IQVIA Holdings beat Wall Street estimates for fourth-quarter profit and revenue on Thursday, helped by the demand for its healthcare data and analytics services.

Light AI Inc. (formerly, Mojave Brands Inc.) ("Light AI" or the "Company") (CBOE CA: ALGO) , a global healthcare technology company focused on developing artificial intelligence health diagnostic and ...